國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁 到查詢結果 [ subject:"Molecular Medicine." ]

切換: 標籤 | MARC模式 | ISBD

Phage therapya practical approach /

Borysowski, Jan.

Phage therapya practical approach /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Phage therapyedited by Andrzej Gorski, Ryszard Miedzybrodzki, Jan Borysowski.
其他題名:	a practical approach /
其他作者:	Gorski, Andrzej.
出版者:	Cham :Springer International Publishing :2019.
面頁冊數:	xv, 385 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
標題:	BacteriophagesTherapeutic use.
電子資源:	https://doi.org/10.1007/978-3-030-26736-0
ISBN:	9783030267360$q(electronic bk.)

Phage therapya practical approach /
Phage therapya practical approach /[electronic resource] :edited by Andrzej Gorski, Ryszard Miedzybrodzki, Jan Borysowski. - Cham :Springer International Publishing :2019. - xv, 385 p. :ill. (some col.), digital ;24 cm.

Part I: Bacteriophages as antibacterialagents -- Chapter 1:Production of PhageTherapeutics and Formulations - InnovativeApproaches -- Chapter 2:Phagepharmacokinetics: relationship with administrationroute -- Chapter 3:BacterialResistance to Phage and itsImpact on Clinical Therapy -- Part II: Bacteriophages and the immune system -- Chapter 4:Phageinteraction with the mammalianimmune system -- Chapter 5:Humoralimmuneresponse to phage-basedtherapeutics -- Part III:Use of bacteriophages to combat bacterial infections -- Chapter 6:How to achieve a goodphage therapy clinical trial? -- Chapter 7: Perspectives on the RenewedInterest in the United States -- Chapter 8:Phage Therapy in Orthopaedic Implant-associated Infections -- Chapter 9:The use of bacteriophages in animalhealth and food protection -- Chapter 10:Combiningbacteriophages with otherantibacterialagents to combatbacteria -- Chapter 11: Phage therapy of infectious biofilms: Challenges and strategies -- Part IV:Phage therapy - regulatory and ethical aspects -- Chapter 12:Regulatory Considerations for Bacteriophage Therapy Products -- Chapter 13:Developing phagesintomedicines for Europe -- Chapter 14: Phagetherapy in Europe: Regulatory and intellectualpropertyprotectionissues -- Chapter 15:Ethics of phagetherapy -- Part V: Bacteriophage-derived antibacterial agents -- Chapter 16: NovelAlternative to Antibiotics.

This book gives a detailed yet clear insight into the current state of the art of the therapeutic application of bacteriophages in different conditions. The authors bring in their practical expertise within their respective fields of expertise and provide an excellent overview of the potential and actual use of phage therapy. Topics like economic feasibility compared to traditional antibiotics and also regulatory issues are discussed in far detail. This new volume is therefore a valuable resource for individuals engaged in the medical application of novel phage therapies.

ISBN: 9783030267360$q(electronic bk.)

Standard No.: 10.1007/978-3-030-26736-0doiSubjects--Topical Terms:

559020
Bacteriophages
--Therapeutic use.

LC Class. No.: QR342 / .P434 2019

Dewey Class. No.: 579.26

Phage therapya practical approach /
LDR:02974nmm a2200325 a 4500 001 567768
003 DE-He213
005 20200116154659.0
006 m d
007 cr nn 008maaau
008 200611s2019 sz s 0 eng d
020 $a 9783030267360$q(electronic bk.)
020 $a 9783030267353$q(paper)
024 7 $a 10.1007/978-3-030-26736-0 $2 doi
035 $a 978-3-030-26736-0
040 $a GP $c GP
041 0 $a eng
050 4 $a QR342 $b .P434 2019
072 7 $a MMFM $2 bicssc
072 7 $a MED052000 $2 bisacsh
072 7 $a MKFM $2 thema
082 0 4 $a 579.26 $2 23
090 $a QR342 $b .P532 2019
245 0 0 $a Phage therapy $h [electronic resource] : $b a practical approach / $c edited by Andrzej Gorski, Ryszard Miedzybrodzki, Jan Borysowski.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a xv, 385 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Part I: Bacteriophages as antibacterialagents -- Chapter 1:Production of PhageTherapeutics and Formulations - InnovativeApproaches -- Chapter 2:Phagepharmacokinetics: relationship with administrationroute -- Chapter 3:BacterialResistance to Phage and itsImpact on Clinical Therapy -- Part II: Bacteriophages and the immune system -- Chapter 4:Phageinteraction with the mammalianimmune system -- Chapter 5:Humoralimmuneresponse to phage-basedtherapeutics -- Part III:Use of bacteriophages to combat bacterial infections -- Chapter 6:How to achieve a goodphage therapy clinical trial? -- Chapter 7: Perspectives on the RenewedInterest in the United States -- Chapter 8:Phage Therapy in Orthopaedic Implant-associated Infections -- Chapter 9:The use of bacteriophages in animalhealth and food protection -- Chapter 10:Combiningbacteriophages with otherantibacterialagents to combatbacteria -- Chapter 11: Phage therapy of infectious biofilms: Challenges and strategies -- Part IV:Phage therapy - regulatory and ethical aspects -- Chapter 12:Regulatory Considerations for Bacteriophage Therapy Products -- Chapter 13:Developing phagesintomedicines for Europe -- Chapter 14: Phagetherapy in Europe: Regulatory and intellectualpropertyprotectionissues -- Chapter 15:Ethics of phagetherapy -- Part V: Bacteriophage-derived antibacterial agents -- Chapter 16: NovelAlternative to Antibiotics.
520 $a This book gives a detailed yet clear insight into the current state of the art of the therapeutic application of bacteriophages in different conditions. The authors bring in their practical expertise within their respective fields of expertise and provide an excellent overview of the potential and actual use of phage therapy. Topics like economic feasibility compared to traditional antibiotics and also regulatory issues are discussed in far detail. This new volume is therefore a valuable resource for individuals engaged in the medical application of novel phage therapies.
650 0 $a Bacteriophages $x Therapeutic use. $3 559020
650 1 4 $a Medical Microbiology. $3 273931
650 2 4 $a Molecular Medicine. $3 273932
700 1 $a Gorski, Andrzej. $3 853343
700 1 $a Międzybrodzki, Ryszard. $3 853344
700 1 $a Borysowski, Jan. $3 853345
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-3-030-26736-0
950 $a Biomedical and Life Sciences (Springer-11642)